AMA #59: Inflammation: its impact on aging and disease risk, and how to identify, prevent, and reduce it

Peter Attia

May 13, 2024

Episode description

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

In this “Ask Me Anything” (AMA) episode, Peter delves into the often misunderstood concept of inflammation. He first defines inflammation and differentiates between acute inflammation and chronic inflammation, the latter of which is linked to aging and a plethora of age-related diseases. Peter breaks down the intricate relationship between chronic inflammation, obesity, and metabolic health, and highlights the signs that might suggest someone may be suffering from chronic inflammation. From there, the conversation centers on actionable advice and practical steps one can take to manage and minimize chronic inflammation. He explores how diet plays a crucial role, including the potential benefits of elimination diets, and he examines the impact of lifestyle factors such as exercise, sleep, and stress management. Additionally, he discusses the relevance of food inflammatory tests and concludes by examining the potential benefits and drawbacks of drugs and supplements in managing inflammation.

If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #59 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

Defining inflammation (and the cultural impact of Napoleon Dynamite) [1:45];
Acute vs chronic inflammation [8:00];
The connection between chronic inflammation, aging, and age-related diseases [11:00];
The impact of inflammation on metabolic health [18:30];
Understanding and diagnosing chronic inflammation: blood tests and other approaches, and challenges with measurement [20:00];
Factors that contribute to low-level ch

Mindsip insights from this episode:

Prioritize holistic methods over targeted drugs to manage inflammation

The risks of targeted drugs suggest that holistic approaches like managing diet, exercise, sleep, and stress are probably a better way to control inflammation.

#inflammation

Weigh risks of targeted anti-inflammatory drugs against benefits

The CANTOS trial showed a drug (canakinumab) targeting a specific inflammatory pathway reduced cardiac events but also increased the risk of serious and fatal infections.

#cancer

#risk

Reduce inflammation to lower mortality risk

In a large study, individuals with very high C-reactive protein (CRP) had a 171% increased risk of death from any cause compared to those with low CRP.

#inflammation

#mortality

Reduce inflammation to lower disease risk

There is a causal relationship between chronic inflammation and diseases like cancer and heart disease, meaning reducing inflammation should reduce disease risk.

#cancer

#inflammation

Detect chronic inflammation through specific testing

Unlike the redness and swelling of acute inflammation, chronic inflammation is low-grade and often asymptomatic, making it difficult to detect without specific tests.

#inflammation

#testing

Address unseen fat to combat inflammation

Inflammation is primarily driven by visceral and ectopic fat around your organs, not the subcutaneous fat that you can see and pinch under the skin.

#inflammation

#visceral-fat

Peter Attia

#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

Building strength and muscle mass: how to optimize training, nutrition, and more for longevity (AMA #71 rebroadcast)

#398 ‒ AMA #86: GLP-1 RAs and muscle loss: new data, better questions, and how to preserve muscle during weight loss

#397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D.

#396 ‒ Breast cancer screening: understanding risk, deciding when to start and how often to screen, and choosing the right imaging strategy